Skip to main content
. 2017 Nov 22;2017(11):CD012216. doi: 10.1002/14651858.CD012216.pub2

NCT02164643.

Trial name or title Longitudinal Study of Brain Amyloid imaGing in MEMENTO (MEMENTOAmyGing)
Target condition and reference standard(s) Cognitive decline over two years of follow‐up, reference standard not specified
Index and comparator tests 18F‐florbetapir and 18F‐flutemetamol
Starting date 2014
Contact information Genevieve Chene, CIC‐EC7 ‐ ISPED ‐ CHU de Bodeaux
Notes